X-Message-Number: 7625
Date: Mon, 3 Feb 1997 02:56:23 -0500 (EST)
From: Charles Platt <>
Subject: Report from the Alcor Technology Festival
Report from the Alcor Technology Festival
by Charles Platt
This report is being typed late on Sunday, February 2. I will
not have time to do an immaculate job, here, but want to
circulate the news as fully and promptly as possible.
The report is in four parts:
1. The Rat Heart Demo
2. Conclusions
3. Other News About Olga Visser
4. The Mystery Ingredient--Revealed
1. The Rat Heart Demo
Even the most antagonistic observer had to feel some sympathy
for Olga Visser when she failed for the fourth time to
resuscitate a frozen rat heart on Sunday, February 2nd, at
the Alcor Cryonics Technology Festival.
Ms. Visser, who has more stamina and determination than her
lean, petite physique suggests, started her first experiment
around 9:30 AM at the Alcor facility in Scottsdale, Arizona.
By 11 AM an audience of 30 visitors had gathered in the
adjacent room, where a large TV showed generally excellent
close-up pictures from Fred Chamberlain's camcorder, which he
had mounted on a small tripod about 18 inches away from
procedures on the lab bench. Attendees were allowed to make
brief personal visits to the lab area, and photographs were
permitted without any restrictions. I took many pictures,
some of which will appear in the next CryoCare Report.
Ms. Visser worked with intent, bird like motions, sometimes
standing, sometimes sitting in front of a metal rack
supporting several vertical tubes drip-fed by small bottles
of colorless fluid. Hugh Hixon sat beside her, watching
temperature graphs on a computer screen, while Fred
Chamberlain, in a jacket and tie, sat at an adjacent desk
monitoring his camcorder.
During a brief appearance before an audience the previous
day, Ms. Visser was asked why she often immersed rat hearts
in liquid nitrogen for only 60 to 90 seconds. Some conference
attendees speculated openly that by using cotton balls to
wrap the hearts, she was protecting them from being cooled
fully to -196 Celsius. This suspicion intensified when we
learned that a temperature probe is not inserted in the heart
itself, or attached to its exterior. Also, since the cotton
wrapping the heart is wet, the water will liberate heat
during its change of state to ice, providing additional
protection.
Ms. Visser's response to these criticisms was immediate and
unflinching. She had no doubt, she said, that the hearts were
being frozen to -196. Therefore, it would make no difference
if they were maintained for 60 seconds or 60 days; and she
vowed to freeze her hearts today for a full 20 minutes.
Initially she perfused a heart for about half an hour with
her secret cryoprotectant, at a temperature between 1 and 2
degrees Celsius. Perfusion is a three-stage process, which I
believe ramps up from weak concentrations to a final value of
20 percent. A gas mixture of 95 percent oxygen, 5 percent
carbon dioxide is bubbled into her cryoprotectant. She uses a
simple gravity-drip-feed connected to a cannula that is
placed in the aorta of the heart.
As I understand it, she perfuses a fixed volume of
cryoprotectant, for whatever length of time it takes. In her
demonstration today she then disconnected the heart from the
cannula, wrapped it in cotton balls, and placed this mass in
a thin-walled plastic cup (very similar to the little cups
that dairy creamer is served in, in fast-food restaurants). A
rubber band was stretched around the mouth of the cup, and
the cup was then placed in some Dacron wool inside a Coke can
from which the top had been removed. This, according to Ms.
Visser, was her way of simulating a cryonics patient being
placed in a dewar.
The Coke can was then dunked in a real (small) dewar of
liquid nitrogen. Observers verified that the can was fully
immersed beneath the surface. Twenty minutes later, it was
removed. The cotton mass--now frozen--was dunked in a
concentrated solution of the Visser cryoprotectant, and was
allowed to soak for about ten minutes before she started
prying the cotton away with tweezers. About another ten
minutes later the heart was revealed, and was a healthy red-
brown color. She reattached it to the cannula and recommenced
flowing cryoprotectant solution through it, gradually warming
it to room temperature.
This, of course, was the moment everyone had been waiting
for. While conference attendees watched impatiently, Ms.
Visser tapped the heart, shook it, prodded it, massaged it,
and forced additional fluid through it under high pressure
from a large syringe. Finally she pierced it with three EEG
probes whose signals were displayed on a CRT screen in a unit
that also emitted audible beeps.
The beeps, however, were erratic and seemed to be generated
each time the assembly was moved or shaken. When Ms. Visser
allowed the heart to dangle undisturbed from its cannula, the
beeps settled into a steady rhythm--which coincided precisely
with drips of cryoprotectant falling from the bottom of the
heart, and seemed to be caused entirely by the associated
fluctuation in conductivity. Ms. Visser suggested that the
heart was in fact pumping the cryoprotectant through it, but
no contractions were visible.
Undaunted, Ms. Visser walked into the other room and told the
audience that the beeps indicated weak ventricular
contractions. This was politely disputed by two attendees,
one of them with formal training as an EEG technician. It was
also noted that the heart had lost its healthy color and
turned gray after being warmed to room temperature. The
blanching indicated typical post-freezing injury, and the
resistance to free flow of fluid through the heart suggested
that the capillary bed had been damaged by freezing. This was
confirmed a little later when the heart was disconnected from
its cannula and cut open.
Even Ms. Visser's supporters were forced to admit that this
heart had not, in fact, resumed beating. Two of them claimed
that they had witnessed a successful experiment on the
previous Friday, when Ms. Visser had arrived to practice her
techniques at the Alcor facility. On that occasion, according
to two witnesses, a heart had pulsed visibly--but this was a
heart that had been immersed in liquid nitrogen for only one
minute. Moreover, even that trial had been preceded by
unsuccessful attempts.
Today (Sunday) Ms. Visser told us that she might not have
time to try again with a second heart. She said that a
mistake had been made; her flight back to South Africa was
supposed to be on Monday, but when she looked at her ticket
this morning she saw that it was valid for this afternoon.
She also said that it was important to buy gifts for her
children, and she planned to go shopping before heading out
to the airport.
This caused some consternation among Alcor personnel, who
huddled briefly with Ms. Visser, called the airline, and
arranged for her ticket to be changed so that she would
return home tomorrow (Monday) as originally promised.
Ms. Visser now had no reason to leave the lab, so she set to
work on another rat. By this time the audience had thinned
out considerably, and I believe some of the people left under
the impression that the first trial had been a success.
Clearly this was not the case, since the heart had showed
such clear evidence of severe freezing damage, and no
contractions had been visible.
The full cycle of dissection/perfusion/immersion/reperfusion
takes about two hours, and entails long periods during which
there is no action at all. The Alcor facility turned into a
low-key non-alcoholic cocktail party as people wandered from
room to room, socializing on a cordial basis. There was no
sign of any animosity, and indeed I believe everyone wanted
the Visser experiment to be a success. Our future, as
cryonicists, would obviously be enhanced by any breakthrough
in cryoprotectants.
Alas, Ms. Visser's second heart of the day was even less
successful than the first. It failed almost completely to
reperfuse, and one observer judged that it was grossly
edematous.
Ms. Visser is a determined woman, however, and promptly
started work on her heart. At this point I left, because the
first two experiments had been so unsuccessful, I found it
hard to believe that the third would do any better. Also the
event was beginning to remind me of experiments to detect
psychic phenomena, which always seem to fail while skeptics
are around. I was frankly embarrassed on behalf of Ms.
Visser, who I think is a sincere woman who believes in her
work.
I returned to the lab around 5 PM and found it virtually
empty. I was told that the third heart had been another
failure, and everyone had gone out to dinner. This turned out
to be a long break; Ms. Visser didn't show up till around
7:30, holding a large sandwich. After eating it, she killed
another rat and set to work on her fourth heart.
By this time the audience had shrunk to only seven hard-core
research enthusiasts: Mike Darwin, Sandra Russell, and Joan
O'Farrell (all from BioPreservation/21st Century Medicine),
myself, Erico Narita, and two others whose names I won't
include because I don't know if they would wish to be
mentioned. Hugh Hixon, Fred Chamberlain, Linda Chamberlain,
and Steve Bridge were also present.
The fourth heart was a problem even before it was frozen. For
reasons that no one could understand it perfused extremely
slowly, as if it contained some kind of interior obstruction.
This time Ms. Visser wrapped it in a thicker layer of cotton
(by my visual estimation) and immersed it in liquid nitrogen
for only four-and-a-half minutes. To no avail: the heart
showed significant cracks when it was removed from its
coccoon, and was clearly damaged beyond repair.
Ms. Visser shook hands all around, we thanked her for her
efforts, and the visitors left the lab.
Conclusions
Absence of evidence is not, as the saying goes, evidence of
absence. The failure of the four trials that we witnessed
does not prove that Ms. Visser's cryoprotectant is useless.
There are still reports that on other occasions, she has been
successful. Tanya Jones, Alcor's Director of Suspension
Services for the past four or five years, told me that she
saw clearly visible contractions of a heart that had been
placed in liquid nitrogen for several minutes.
Still, I have to say I was troubled by the obvious lack of
experimental rigor. Ms. Visser changes her parameters and
procedures in an impulsive style, like a chef deciding to add
a little more salt or a little less sugar each time she cooks
a particular dish. I was told that the final concentration of
her solution was 25 percent during some previous trials;
tonight, for reasons unspecified, it was 20 percent. The
procedure for wrapping the heart seemed to vary from one time
to the next, and the Coke can was pre-filled with liquid
nitrogen during the second trial that I witnessed, while it
was not pre-filled during the first trial (so far as I was
able to see).
I am also troubled by Ms. Visser's initial claim that the
first heart in today's series was a success. She did not
formally retract this claim, but ultimately did admit that
her experiments today were a failure. Of course I realize
that she was operating under considerable pressure, in front
of an audience containing several critics, and she must have
felt a great need to vindicate her procedure. This cannot
excuse, however, a false claim; and a false claim was made.
It remains unclear whether her procedure for wrapping rat
hearts does in fact provide significant protection from
liquid-nitrogen temperatures. When challenged on this subject
today, she cut off a piece of rat liver, approximately the
same size as a heart, wrapped it in cotton, dunked it for 90
seconds, then removed it and applied a temperature probe that
showed it was, in fact, below -190 Celsius. On the other
hand, I noticed that in her fourth heart today she added
considerably more protective cotton. I also noticed that
Alcor personnel did not always check that her hearts were
completely immersed in the dewar of liquid nitrogen. Even if
they had been more rigorous, immersion is almost impossible
to judge during a short period, because vapor in the dewar
takes a couple of minutes to clear, and during that time
there is no way to see the sample.
I also note that observers typically become inattentive
during a number of unsuccessful trials. I myself failed to
notice, tonight, when Ms. Visser removed her fourth heart
from perfusion and placed it in the dewar. I was tired and
was momentarily distracted. I believe that Ms. Visser is
sincere and honorable, but if she were tempted to cut any
corners in her procedures, it would be relatively easy to do
so after some unsuccessful attempts. Of course, a properly
situated probe inside the heart, or attached to its outside,
would allay these doubts; but I was told that no such probe
has been used.
Bearing all this in mind, and also bearing in mind the severe
freezing damage that I witnessed, I have to conclude that I
found absolutely no evidence in favor of Ms. Visser's
cryoprotectant. It's still possible, of course, that we were
just unlucky today, and valid results may have been obtained
previously.
Other News About Olga Visser
On Saturday (the first day of the Alcor conference) Ms.
Visser stood before an audience of about 40 attendees and
made a short speech urging cryonicists to cooperate and work
together. She obviously realized that this plea for harmony
contrasted oddly with her online persona. "A lot of people
probably thought I'd ride in on a broom," she said. But she
told us that she is a shy, decent, pleasant person. In fact,
she claimed that her combative messages on the Net were not
written by her at all. Her husband Zigi had typed some of
them; others had been composed by an employee of the South
African Government who has been assigned to protect Ms.
Visser from her critics and keep her away from journalists at
all times. Ms. Visser said that the only messages she wrote
herself were the strictly factual ones describing
experimental procedure.
Well, I already noticed that the factual messages were
formatted with a different line length from the ones that
flamed her critics so savagely. On the other hand, as one
cynic remarked, if Ms. Visser suffers from multiple
personality disorder, we should expect her hostile
personality to use different text formatting from her kinder,
gentler personality.
After her short self-introduction, Ms. Visser mentioned a few
interesting details about her work. She said she had frozen a
pig heart initially, but switched to rat hearts because they
are cheaper and more plentiful. Funding is obviously a
problem in South Africa, where the government gives highest
priority to AIDS research. Ms. Visser said that she did not
get her own laboratory until a month ago, and she had been
constantly frustrated by the unwillingness of assistants to
work long hours. She hopes ultimately to relocate in the
United States, where people are more willing to work hard.
She endorsed the concept of cryonics. "The hope of everyone
is to be young forever," she said. Ideally, we should eat
right, not smoke, and "live in the woods" (presumably, away
from pollution). Still, she said, "since this is not
possible, the second-best way is to be frozen and come back
in perfect health at a time when all diseases can be cured."
I noted that Ms. Visser herself is a fairly heavy smoker.
When she was asked why her research hasn't been repeated
elsewhere, she responded that a group in Australia is working
on livers using her proprietary cryoprotectant. "They brought
a liver back that was stored for three days," she claimed.
"And we have people working in London as well." She did not
specify names of researchers, or affiliations.
Her next step, she said, will be to cryopreserve a pig heart,
keep it in liquid nitrogen for a few days, then rewarm it and
transplant it back into a pig. Since she belongs to a
thoracic surgery department, she is not allowed to work on
any organ other than hearts. She does want to expand her
techniques to other organs, though, and sees no reason why
her cryoprotectant shouldn't scale up to preserve human
brains. She also wants to establish a bank of frozen skin,
because the European skin grafts that are imported to South
Africa are unsuitable for Black Africans.
When will we learn the composition of her cryoprotectant?
"Very soon," she said. By this she seemed to mean that the
news will be circulated when her paper on rat hearts is
finally published.
On this topic, the news is as follows. The rat-heart paper
was the first paper she ever wrote. In her naivety, she
failed to include some procedural details. Consequently, the
paper was sent back for revisions, which have now been made.
She claims that her coworkers want to submit the paper to
Science magazine, but she feels that it would be "unfair" not
to resubmit it to the cryobiology magazine where it was
originally sent. She is hoping to do this "soon" and hopes
for publication "before June."
She finished up with a telling self-description. "If I want
to do something," she said, "I do it. I go against most other
people, I'll just go ahead and do it, in any country, and
then I'll answer questions afterward."
Unfortunately, she had been warned by her lawyers not to
answer any questions about her AIDS research, so we learned
nothing new on this topic.
Mystery Ingredient--Revealed
While Ms. Visser's agents were busily threatening to sue
anyone and everyone who dared to state the composition of the
VisserStuff online, I have to report that a fairly well known
Alcor member inadvertantly confirmed to me that Ms. Visser's
cryoprotectant is, in fact, exactly the stuff that many
people have said it is. The Alcorian speculated that trace
impurities may be the reason why Visser's stock of the
chemical, which originates in South Africa, has worked on rat
hearts while American attempts to duplicate her work have
failed. In other words, the Alcorian did _not_ suggest that
the U.S. researchers have been using the wrong chemical
altogether; merely that their supply of it may be slightly
polluted. Subsequently, a _second_ Alcorian said exactly the
same thing.
I believe this removes the last vestige of mystery from the
mystery ingredient. We know what it is; now we just need some
repeatable results. I understand that Alcor has been unable
to obtain these results when Ms. Visser is not present. I
hope someone, somewhere will be able to do so; otherwise,
Olga Visser's claims will remain unverified.
PS. In her rat-heart experiments today (Sunday) Ms. Visser
used a supply of cryoprotectant that she brought with her
from South Africa.
Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=7625